<DOC>
	<DOCNO>NCT00884143</DOCNO>
	<brief_summary>There different type hormonal therapy medicine treatment hormone-receptor-positive breast cancer . The purpose study determine evolution two type hormonal treatment ( drug call `` tamoxifen '' group medicine call `` aromatase inhibitor '' ) two time period 12 month , year 2006 2008 , northeast Italian region . The study include post-menopausal woman initiate hormonal therapy medicine 2006 . The study also verify rate implementation update national international recommendation use adjuvant hormonal therapy hormone-receptor-positive breast cancer .</brief_summary>
	<brief_title>Observational Triveneto Study Use Adjuvant Hormonal Therapies Treatment Hormone-responsive Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Postmenopausal patient surgically treat breast cancer start adjuvant hormonal therapy January 2006 December 2006 January 2008 December 2008 Documented evidence way adjuvant hormonal treatment initiate . Pre perimenopausal patient surgically treat breast cancer start adjuvant hormonal therapy Patients already enrol clinical study aim investigate hormone therapy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>tamoxifen</keyword>
	<keyword>arimidex</keyword>
	<keyword>adjuvant hormonal therapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>post-menopausal</keyword>
	<keyword>Adjuvant hormonal therapy patient post menopausal breast cancer</keyword>
</DOC>